RNA-dependent RNA polymerase encoded by hepatitis C virus: Biomedical applications

Cellular and Molecular Life Sciences

Volumn 59, Issue 6, 2002, Pages 909-919

  Leveque V J P ^a   Wang, Q M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antiviral therapy; HCV; Polymerase inhibitor; Viral RNA dependent RNA polymerase

Indexed keywords

ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BUTYRIC ACID DERIVATIVE; DIHYDROXYCARBOXYPYRIMIDINE DERIVATIVE; DIKETOBUTANOIC ACID; NUCLEOSIDE ANALOG; PROTEIN NS5B; PYRIMIDINE DERIVATIVE; RHODANINE; RNA DIRECTED RNA POLYMERASE; RNA DIRECTED RNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS RNA;

CHRONIC HEPATITIS; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; ENZYME INHIBITORS; HEPACIVIRUS; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RNA NUCLEOTIDYLTRANSFERASES; RNA REPLICASE; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0036308231     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8478-7     Document Type: Review

References (85)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Hepatitis C virus infection is associated with development of hepatocellular carcinoma
3. The scientific challenge of hepatitis C
4. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups
5. The molecular virology of hepatitis C
6. Molecular characterization of hepatitis C virus
7. A second hepatitis C virus-encoded proteinase
8. Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein
9. Hepatitis C virus NS3/4A protease
10. Structure and function of hepatitis C virus NS3 helicase
11. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing
12. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation
13. The non-structural 5A protein of hepatitis C virus
14. Hepatitis C virus RNA-dependent RNA polymerase
15. Hepatitis C treatment
16. Strategies and prospects for vaccination against the hepatitis C viruses
17. Emerging therapies for hepatitis C virus infection
18. Recent advances in prevention and treatment of hepatitis C virus infections
19. New therapeutic strategies for hepatitis C
20. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: A comparison with ribavirin and demonstration of antiviral additivity with alpha interferon
21. Hepatitis C virus: Current understanding and prospects for future therapies
22. Targets for inhibition of hepatitis C virus replication
23. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus
24. Expression of hepatitis C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding
25. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
26. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region
27. A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA
28. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli
29. Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence
30. Expression, purification, and partial characterization of HCV RNA polymerase
31. Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli
32. Specificity and mechanism analysis of hepatitis C virus RNA-dependent RNA polymerase
33. De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus
34. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase
35. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
36. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
37. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
38. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides
39. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
40. Structural basis for initiation of transcription from an RNA polymerase-promoter complex
41. A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase
42. Protein-primed RNA synthesis by purified poliovirus RNA polymerase
43. De novo initiation of RNA synthesis by hepatitis C virus non-structural protein 5B polymerase
44. De novo RNA synthesis catalyzed by HCV RNA-dependent RNA polymerase
45. Template requirement for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase
46. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template
47. Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus
48. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP
49. Kinetic analysis of C-terminally truncated RNA-dependent RNA polymerase of hepatitis C virus
50. Genome-length copies of poliovirion RNA are synthesized in vitro by the poliovirus RNA-dependent RNA polymerase
51. Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: Implications for viral replication and in vitro assays
52. Poliovirus RNA-dependent RNA polymerase (3D(pol)): Divalent cation modulation of primer, template, and nucleotide selection
53. DNA polymerases: Structural diversity and common mechanisms
54. Functional oligomerization of poliovirus RNA-dependent RNA polymerase
55. Structure of the RNA-dependent RNA polymerase of poliovirus
56. Oligomerization and cooperative RNA-synthesis activity of hepatitis C virus RNA-dependent RNA polymerase
57. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase
58. Oligomeric structures of poliovirus polymerase are important for functions
59. Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase
60. Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: Implication for viral RNA synthesis
61. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons
62. Hepatitis C virus NS5B RNA replicase specifically binds ribosomes
63. HCV RNA-dependent RNA polymerase replicates in vitro the 3′ terminal region of the minus-strand viral RNA more efficiently than the 3′ terminal region of the plus RNA
64. Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3′ end of the viral RNA
65. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus
66. Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase
67. Hepatitis C virus NS5A binds RNA-dependent RNA polymerase NS5B and modulates RdRP activity
68. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein
69. Identification of a cellular protein interacting with RNA polymerase of hepatitis C virus
70. Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization
71. Characterization of hepatitis C virus polymerase expressed in mammalian cells: Phosphorylation is essential for its polymerase activity
72. The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations
73. Diketobutanoic acids as HCV polymerase inhibitors
74. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
75. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin
76. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase
77. Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase